Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H34N5O14P |
InChIKeyVCMJCVGFSROFHV-WZGZYPNHSA-N |
CAS Registry202138-50-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | - | - | |
HIV Infections | Phase 1 | - | - | - |
HIV Infections | Phase 1 | - | - | |
HIV Infections | Phase 1 | - | - |
Early Phase 1 | 10 | (TDF (Single IVR)) | jcafkkidus(njnpqynzpc) = zflrgjxpeq mwqalzhiqm (stujldhsvm, dygmezfpto - aamtccmyht) View more | - | 02 Jul 2019 | ||
TDF-FTC IVR (TDF-FTC (Dual IVR)) | jcafkkidus(njnpqynzpc) = umfvlfpbjs mwqalzhiqm (stujldhsvm, hbydckpeyi - zcokhlngpm) View more |